Keywords: Shire, Management team. R&D

Shire strengthens R&D team with former GSK and Abbott execs

Article | 09 February 2011

Print This

Biopharma specialist Shire (LSE: SHP; Nasdaq: SHPGY) has appointed two senior R&D executives to its Specialty Pharmaceuticals business. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in